- Home
- MMI vs BLFS Comparison
MMI vs BLFS Comparison
Compare MMI & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- BLFS
- Stock Information
- Founded
- MMI 1971
- BLFS 1987
- Country
- MMI United States
- BLFS United States
- Employees
- MMI N/A
- BLFS 159
- Industry
- MMI Real Estate
- BLFS Medical/Dental Instruments
- Sector
- MMI Finance
- BLFS Health Care
- Exchange
- MMI Nasdaq
- BLFS Nasdaq
- Market Cap
- MMI 1.2B
- BLFS 1.3B
- IPO Year
- MMI 2013
- BLFS 1989
- Fundamental
- Price
- MMI $29.25
- BLFS $27.30
- Analyst Decision
- MMI Hold
- BLFS Strong Buy
- Analyst Count
- MMI 1
- BLFS 7
- Target Price
- MMI N/A
- BLFS $30.86
- AVG Volume (30 Days)
- MMI 134.5K
- BLFS 388.7K
- Earning Date
- MMI 11-07-2025
- BLFS 11-11-2025
- Dividend Yield
- MMI 1.71%
- BLFS N/A
- EPS Growth
- MMI N/A
- BLFS N/A
- EPS
- MMI N/A
- BLFS N/A
- Revenue
- MMI $725,903,000.00
- BLFS $93,468,000.00
- Revenue This Year
- MMI $9.50
- BLFS $26.07
- Revenue Next Year
- MMI $17.73
- BLFS $16.86
- P/E Ratio
- MMI N/A
- BLFS N/A
- Revenue Growth
- MMI 17.89
- BLFS 68.16
- 52 Week Low
- MMI $27.35
- BLFS $19.10
- 52 Week High
- MMI $42.80
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- MMI 46.01
- BLFS 55.07
- Support Level
- MMI $28.79
- BLFS $26.01
- Resistance Level
- MMI $29.62
- BLFS $29.04
- Average True Range (ATR)
- MMI 0.67
- BLFS 1.11
- MACD
- MMI 0.14
- BLFS 0.10
- Stochastic Oscillator
- MMI 80.67
- BLFS 58.39
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.